Dendreon Pharmaceuticals LLC

SEAL BEACH,  CA 
United States
https://www.dendreon.com
  • Booth: 834

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of treatments that harness the power of the immune system to extend life. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 30,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif. For more information, please visit www.dendreon.com.

Brands: PROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy made from a patient’s own immune cells and has been prescribed to more than 30,000 men with advanced prostate cancer in the U.S.